A new gene therapy for an ultra-rare disease will have a wholesale cost of $4.25 million, making it the world’s most expensive drug. The one-time treatment, Lenmeldy, won U.S. regulatory ...

In the pre-separation deal presentation, Worthington described its steel processing business in greater detail. The company is a premium steel processor which delivered 4 million tons of steel in ...

Worthington Industries' shares have risen 30% since separating from Worthington Steel, creating value for investors. As an undervalued and stable business, it has seen a re-rating in a tougher ...

Monday, Seaport Global Securities initiated coverage on Worthington Steel Inc (NYSE:WS) with a Neutral rating. The firm acknowledged the company's potential in long-term secular ...

Following the move, Worthington now trades at about 13.7 times projected earnings. That's within range of the multiples ...

Worthington Steel, Inc. (NYSE:WS) shares are skyrocketing on Friday. The company reported third quarter fiscal 2024 adjusted ...

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

That's within range of the multiples assigned to market giant U.S. Steel (11.7 times) and disruptor Nucor (14.4 times). It is hard to imagine Worthington ... to building the world's greatest ...

Worthington Steel, Inc. engages in the provision of steel processing business in connection with the separation and the distribution. Its products include cold rolled steel, hot rolled ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...